| |
We develop the appropriate formulation that meets the requirements of:
- Route of Administration
– Transdermal
– Parenteral
– Oral
- Special Formulations
– Microspheres
– Cyclodextrins
- Physico-Chemical Properties of the Active Pharmaceutical Ingredient
- Limited aqueous Solubility
– Nanoparticles
– Solubilization Enhancement by e.g.
– Micellar Solubilization
- Phase of your Development Project
- Preclinical Supplies
- Clinical Supplies
- Toxicology
- Safety Pharmacology
- Mutagenicity
- Carcinogenicity
- Adapted to Species and Individual Animal
- Process Development
- Use of PAT (Process Analytical Technology) Concept of the FDA
|
